Procurement of 17 Essential Drugs for Karnataka Health Institutions

Work Description - NA

This tender, under Bid Number GEM/2026/B/7785962, is issued by the Karnataka State Medical Supplies Corporation Ltd, a part of the Health and Family Welfare Department of Karnataka. The tender pertains to the procurement of 17 essential drugs for various Health Institutions across Karnataka, as detailed in the Bill of Quantities (BOQ). The procurement process is scheduled to commence on July 15, 2026, at 1:16 PM and will conclude on August 13, 2026, at 5:00 PM. The total quantity of items required across all listed drugs is substantial, amounting to 53,300,513 units. The specific drugs and their formulations include Baclofen Tablet IP 20 mg, Dabigatran Etexilate Capsule 110 mg USP, Ferrous Sulphate Tablet IP 200 mg (equivalent to 60 mg elemental Iron), Ascorbic Acid Tablet IP 100 mg (Vitamin C), Hydroxyzine Oral Solution IP 10 mg per 5 ml, Cyclosporine Oral Solution IP 100 mg per ml, Sucralfate Tablet IP 1 g, Potassium permanganate Crystals IP 100 gm, Drotaverine HCl and Aceclofenac Tablet IP, Formoterol Fumarate and Budesonide powder for Inhalation IP, Hydrocortisone Tablets USP 10 mg, Sodium Hypochlorite Solution IP 10 percent, Glycerin Oral Solution IP 25 g, Desonide Cream USP 0.05 percent w/w, Ispaghula Husk Granules BP, Potassium Nitrate medicated Topical Solution USP 5 percent, and Liquid Paraffin Emulsion IP 100 ml. Interested and eligible suppliers are invited to participate in this significant procurement opportunity aimed at strengthening healthcare services within the state of Karnataka.